Charles V. Sanders

2.8k total citations
94 papers, 2.0k citations indexed

About

Charles V. Sanders is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Charles V. Sanders has authored 94 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 30 papers in Epidemiology and 22 papers in Clinical Biochemistry. Recurrent topics in Charles V. Sanders's work include Bacterial Identification and Susceptibility Testing (22 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Charles V. Sanders is often cited by papers focused on Bacterial Identification and Susceptibility Testing (22 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Charles V. Sanders collaborates with scholars based in United States and China. Charles V. Sanders's co-authors include Kenneth E. Aldridge, K E Aldridge, Robert L. Marier, Adeel A. Butt, Stephanie N. Taylor, James P. Luby, Jay P. Sanford, Fred A. Lopez, Jack A. Barnett and W. G. Johanson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Charles V. Sanders

91 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles V. Sanders United States 27 739 658 366 319 289 94 2.0k
M. Rozenberg-Arska Netherlands 27 927 1.3× 425 0.6× 235 0.6× 304 1.0× 149 0.5× 82 1.9k
Gary D. Overturf United States 30 1.1k 1.5× 662 1.0× 146 0.4× 267 0.8× 378 1.3× 88 2.5k
F. Gudiol Spain 26 1.1k 1.5× 336 0.5× 262 0.7× 236 0.7× 202 0.7× 45 2.3k
Nord Ce Sweden 26 681 0.9× 808 1.2× 374 1.0× 275 0.9× 425 1.5× 122 2.2k
D. C. E. Speller United Kingdom 27 872 1.2× 993 1.5× 410 1.1× 236 0.7× 287 1.0× 88 2.3k
W. J. Martone United States 27 807 1.1× 802 1.2× 351 1.0× 183 0.6× 467 1.6× 40 2.7k
K. V. I. Rolston United States 34 1.5k 2.0× 1.0k 1.5× 631 1.7× 501 1.6× 219 0.8× 86 3.5k
N Lambert-Zechovsky France 27 593 0.8× 635 1.0× 284 0.8× 219 0.7× 447 1.5× 115 2.2k
E. Dale Everett United States 23 655 0.9× 1.1k 1.6× 504 1.4× 248 0.8× 699 2.4× 48 2.5k
Gale B. Hill United States 22 697 0.9× 365 0.6× 439 1.2× 137 0.4× 646 2.2× 45 2.1k

Countries citing papers authored by Charles V. Sanders

Since Specialization
Citations

This map shows the geographic impact of Charles V. Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles V. Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles V. Sanders more than expected).

Fields of papers citing papers by Charles V. Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles V. Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles V. Sanders. The network helps show where Charles V. Sanders may publish in the future.

Co-authorship network of co-authors of Charles V. Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of Charles V. Sanders. A scholar is included among the top collaborators of Charles V. Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles V. Sanders. Charles V. Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanders, Charles V., et al.. (2017). Cutaneous Tuberculosis. Microbiology Spectrum. 5(1). 33 indexed citations
2.
Cuchacovich, Raquel, et al.. (2011). Vasculopathy, Hematological, and Immune Abnormalities Associated with Levamisole-Contaminated Cocaine Use. Seminars in Arthritis and Rheumatism. 41(3). 445–454. 33 indexed citations
3.
Sanders, Charles V.. (2011). The 2011 Southern Society of Clinical Investigation President’s Symposium: Sexually Transmitted Infections—Evolving Concepts. The American Journal of the Medical Sciences. 343(1). 1–1.
4.
Sanders, Charles V.. (2008). Southern Society for Clinical Investigation Founders’ Medal Acceptance. The American Journal of the Medical Sciences. 336(1). 8–9. 1 indexed citations
6.
Lopez, Fred A. & Charles V. Sanders. (2001). DERMATOLOGIC INFECTIONS IN THE IMMUNOCOMPROMISED (Non-HIV) HOST. Infectious Disease Clinics of North America. 15(2). 671–702. 16 indexed citations
7.
Sanders, Charles V. & Lee T. Nesbitt. (1995). The skin and infection : a color atlas and text. Williams & Wilkins eBooks. 9 indexed citations
8.
Sanders, Charles V.. (1994). Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: A review. Intensive Care Medicine. 20(S3). S21–S26. 7 indexed citations
9.
Aldridge, Kenneth E., et al.. (1990). In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. Journal of Antimicrobial Chemotherapy. 26(3). 353–359. 4 indexed citations
10.
Spencer, Charles H., et al.. (1989). Fusobacterium necrophorum Sepsis With Cerebral Infarction. Southern Medical Journal. 82(8). 1040–1043. 9 indexed citations
12.
Besch, Camille & Charles V. Sanders. (1986). Managing sepsis--a common cause of geriatric death.. PubMed. 41(4). 55–7, 60. 3 indexed citations
13.
Aldridge, K E, Charles V. Sanders, & Robert L. Marier. (1984). In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.. PubMed. 2(3 Suppl). 47S–53S. 20 indexed citations
15.
Sanders, Charles V. & Kenneth E. Aldridge. (1983). The microbiology laboratory: Garbage in, garbage out. Clinical Microbiology Newsletter. 5(18). 123–125.
16.
Sanders, Charles V., et al.. (1983). Vibrio vulnificus infection. Journal of the American Academy of Dermatology. 9(2). 243–251. 39 indexed citations
17.
Marier, Robert L., et al.. (1982). Susceptibility patterns of bacteria following therapy with piperacillin. Journal of Antimicrobial Chemotherapy. 9(suppl B). 85–91. 7 indexed citations
18.
TADDONIO, RUDOLPH F., et al.. (1979). Spondylitis Caused by Brucella abortus. Southern Medical Journal. 72(9). 1166–1169. 11 indexed citations
19.
Sanders, Charles V., et al.. (1976). Splinter Hemorrhages and Onycholysis. Southern Medical Journal. 69(8). 1090–1093. 9 indexed citations
20.
Luby, James P., Charles V. Sanders, & S. Edward Sulkin. (1971). Interferon Assays and Quantitative Virus Determinations in a Fatal Infection in Man with Western Equine Encephalomyelitis Virus. American Journal of Tropical Medicine and Hygiene. 20(5). 765–769. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026